Fig. 4

Dynamic changes of LY6E and TRIM6 mRNA levels in the VR group and NVR group. (A-B) LY6E mRNA levels during therapy in the VR group and NVR group. (D-E) TRIM6 mRNA levels during therapy in the VR group and NVR group. (C, F) LY6E and TRIM6 mRNA levels in the VR group and NVR group were compared and at 0 weeks, 12 weeks and 24 weeks of therapy. LY6E and TRIM6 mRNA levels in PBMCs were measured by qRT-PCR. Values are described by median (interquartile range). P < 0.05 was statistically significant